Ready to play
Ready to play
A recent study showed that using GLP-1 weight loss medications among children and adolescents is associated with a risk of nutrient deficiencies. About 17% of users aged 10 to 17 were diagnosed with nutritional deficiencies within one year of starting treatment. The most common cases were vitamin D deficiency at 12%, nutritional anemia at 1.55%, and iron deficiency at 1.44%. The researchers emphasized that nutrient deficiencies pose a significant risk that should be monitored early. Although the study did not establish a direct causal link between the medications and deficiencies, it highlights the importance of nutritional management during treatment to ensure children’s dietary needs are met during their growth phase.
Notice: This Is an AI-Generated Summary
Comments (0)